Qingqing Cai, MD, PhD, explains why the dual-binding profile of rocbrutinib supports pairing it with R-CHOP for newly diagnosed B-cell lymphoma.
Qingqing Cai, MD, PhD
Advertisement
Qingqing Cai, MD, PhD, is a deputy director of the Department of Medical Oncology, a professor, and a chief physician at Sun Yat-sen University Cancer Center.
Articles by Qingqing Cai, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
DLL3-Targeted Therapy and KRAS Inhibition Lead Lung Cancer Data Highlights From ESMO 2026
2
Dr Garrido-Laguna on the Efficacy and Safety of QTX3034-Based Combinations in KRAS G12D–Mutated CRC
3
Rocbrutinib Plus R-CHOP Elicits Responses in Previously Untreated B-Cell Lymphomas
4
Lirafugratinib Added to NCCN Guidelines for Previously Treated FGFR2-Rearranged CCA
5